Immuneering (IMRX) Current Leases (2020 - 2024)
Historic Current Leases for Immuneering (IMRX) over the last 5 years, with Q3 2024 value amounting to $324702.0.
- Immuneering's Current Leases rose 764.8% to $324702.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $324702.0, marking a year-over-year increase of 764.8%. This contributed to the annual value of $300107.0 for FY2023, which is 2075.82% down from last year.
- Per Immuneering's latest filing, its Current Leases stood at $324702.0 for Q3 2024, which was up 764.8% from $311459.0 recorded in Q2 2024.
- In the past 5 years, Immuneering's Current Leases registered a high of $378723.0 during Q4 2022, and its lowest value of $76322.0 during Q4 2020.
- In the last 5 years, Immuneering's Current Leases had a median value of $300107.0 in 2023 and averaged $265688.5.
- Per our database at Business Quant, Immuneering's Current Leases surged by 27284.14% in 2022 and then crashed by 2075.82% in 2023.
- Quarter analysis of 5 years shows Immuneering's Current Leases stood at $76322.0 in 2020, then soared by 259.06% to $274039.0 in 2021, then surged by 38.2% to $378723.0 in 2022, then dropped by 20.76% to $300107.0 in 2023, then rose by 8.2% to $324702.0 in 2024.
- Its last three reported values are $324702.0 in Q3 2024, $311459.0 for Q2 2024, and $298543.0 during Q1 2024.